Biopharmaceutical New Technologies Inc. (BNTX) stock fell during current market, here’s what’s happening

Biopharmaceutical New Technologies Inc. (NASDAQ: BNTX) stock declined by 8.64% in the current market trading session. Biopharmaceutical New Technologies is a next-generation immunotherapy firm that is developing innovative cancer and other critical disease treatments. BNTX stock’ Major Update The FDA has extended the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 […]